Latest reported quarter: Q2, ended Jul 2026
Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $730.50M | $705.50M | $750.60M | $669.90M | $682.10M |
| Total Operating Revenue | $730.50M | $705.50M | $750.60M | $669.90M | $682.10M |
| Cost of Revenue | $323.50M | $315.40M | $340.00M | $299.70M | $312.20M |
| Gross Profit | $407.00M | $390.10M | $410.60M | $370.20M | $369.90M |
| Operating Expense | $326.70M | $323.90M | $317.60M | $312.70M | $323.60M |
| Selling and Admin Expenses | $296.30M | $293.90M | $285.50M | $284.40M | $295.30M |
| Research & Development | $30.40M | $30.00M | $32.10M | $28.30M | $28.30M |
| Operating Profit | $80.30M | $66.20M | $93.00M | $57.50M | $46.30M |
| Net Non-Operating Interest Income (Expense) | -$8.70M | -$7.40M | -$10.30M | -$9.00M | -$8.00M |
| Non-Operating Interest Expense | $8.70M | $7.40M | $10.30M | $9.00M | $8.00M |
| Other Income (Expense) | $2.80M | -$6.60M | -$25.10M | $1.40M | $2.40M |
| Other Non-Operating Income (Expenses) | $2.80M | -$2.90M | -$5.40M | $1.40M | $2.40M |
| Pretax Profit | $74.40M | $52.20M | $57.60M | $49.90M | $40.70M |
| Tax | $20.70M | $13.50M | $24.70M | $80.20M | $14.30M |
| Net Profit | $53.70M | $38.70M | $32.90M | -$30.30M | $26.40M |
| Profit from Continuing Operations | $53.70M | $38.70M | $32.90M | -$30.30M | $26.40M |
| Net Income to Parent Company | $53.70M | $38.70M | $32.90M | -$30.30M | $26.40M |
| Net Income to Common Stockholders | $53.70M | $38.70M | $32.90M | -$30.30M | $26.40M |
| Basic EPS | $0.33 | $0.24 | $0.20 | -$0.18 | $0.16 |
| Diluted EPS | $0.33 | $0.23 | $0.20 | -$0.18 | $0.16 |
| Special Income (Charges) | – | -$3.70M | -$19.70M | $0.00 | – |
| -Less:Restructuring and Mergern & Acquisition | – | $3.70M | – | – | – |
| -Less:Impairment of Capital Assets | – | – | $0.00 | $0.00 | – |
| Line item | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2021 ANNUAL |
|---|---|---|---|---|---|
| Operating Cash Flow | $275.70M | $336.50M | $275.70M | $182.70M | $361.60M |
| Net cash flow from continuing operations | $275.70M | $336.50M | $275.70M | $182.70M | $361.60M |
| Net Income from Continuing Operations | $47.00M | -$1.12B | -$100.20M | $243.10M | $340.50M |
| Gain/Loss from Continuing Operations | $4.20M | $3.20M | -$9.00M | -$10.80M | -$13.90M |
| Depreciation & Depletion & Amortization | $150.70M | $154.50M | $162.60M | $162.10M | $151.90M |
| Deferred Tax | $11.40M | -$29.00M | -$37.00M | – | – |
| Other Non-Cash Items | $4.20M | $4.90M | $34.40M | $18.30M | $34.10M |
| Change in Working Capital | $8.90M | $97.40M | -$71.40M | -$271.70M | -$203.20M |
| -Change in Receivables | -$48.50M | $10.00M | -$17.00M | -$71.00M | -$43.20M |
| -Change in Inventory | -$29.10M | $3.60M | $35.10M | -$39.90M | -$66.00M |
| -Change in Prepaid Assets | $7.70M | -$6.70M | $3.30M | -$11.70M | -$11.50M |
| -Change in Payables and Accrued Expense | $123.50M | $133.30M | -$58.30M | -$88.50M | $14.00M |
| -Change in Other Current Liabilities | -$44.70M | -$42.80M | -$34.50M | -$31.60M | -$37.50M |
| Net cash flow from investing | -$51.10M | -$54.60M | -$62.40M | -$657.30M | $262.70M |
| Net Cash Flow from Continuing Investing Activities | -$51.10M | -$54.60M | -$62.40M | -$657.30M | $262.70M |
| Net PPE Purchase and Sale | -$44.80M | -$33.70M | -$52.10M | -$72.40M | -$43.10M |
| Net Business Purchase and Sale | $0.00 | $400,000.00 | $10.70M | -$622.30M | $310.40M |
| Net Investment Purchase and Sale | $500,000.00 | -$23.50M | $0.00 | $56.00M | $11.40M |
| Net Other Investing Changes | -$6.80M | $2.20M | -$21.00M | -$18.60M | -$16.00M |
| Financing Cash Flow | -$170.90M | -$103.70M | $118.90M | $12.50M | -$465.60M |
| Net Cash Flow from Continuing Financing Activities | -$170.90M | -$103.70M | $118.90M | $12.50M | -$465.60M |
| Net Issuance Payments Of Debt | -$900,000.00 | -$100.00M | $133.70M | -$200,000.00 | -$475.70M |
| Net Common Stock Issuance | -$166.60M | $0.00 | $0.00 | – | – |
| Proceeds from Stock Option Exercised | $2.80M | $2.40M | $11.30M | $21.80M | $19.50M |
| Net Other Financing Charges | -$6.20M | -$6.10M | -$26.10M | -$9.10M | -$9.40M |
| Ending Cash Balance | $1.21B | $1.07B | $940.00M | $606.90M | $1.07B |
| Net Change in Cash | $53.70M | $178.20M | $332.20M | -$462.10M | $158.70M |
| Beginning Cash Balance | $1.07B | $940.00M | $606.90M | $1.07B | $888.90M |
| Effect of Exchange Rate Changes | $88.90M | -$49.10M | $900,000.00 | -$4.60M | $26.00M |
| Free Cash Flow | $230.40M | $302.70M | $217.50M | $107.00M | $306.90M |
| -Change In Other Working Capital | – | – | – | -$29.00M | -$59.00M |
No comments yet — be the first to weigh in on NVST.